← check another ticker
IOVA
Iovance Biotherapeutics, Inc.
8
Extremely Regarded
Regard Score: 8/10
$4.28$1.9B market cap

Score Breakdown

🤖AI Rating
6/10

Below average.

💸Valuation
5/10

Negative cash flow. Can't value it.

P/S: 6.7x
TTM Growth: +44.8%
🔍Filing Risk
5/10

Some yellow flags.

Overall Risk: 5/10
Fraud Risk: 0/10
Dilution Risk: 0/10
🖨️Dilution
7/10

Shares melting fast.

Annual Dilution: +33.7%
🏃Insider Selling
5/10

No data.

⏳Cash Runway
9/10

Tight but ok.

Months Left: 12
🩳Short Interest
8/10

Heavy bearish bets.

% of Float Shorted: 34.5%
Days to Cover: 7.9
🤡Management
5/10

No data.

Exec Pay (% Rev): 16.4%
🔔 Want to know when IOVA stops being regarded?
Get an email when the regard score changes.
No spam, just alerts.